7 Fastest Growing European Stocks to Invest In
European stocks are getting a closer look again, and not only because investors want to diversify away from a crowded U.S. trade.
Beone Medicines Ltd. (ONC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 116 | $34,449 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $302.06 | 165,529 | $49,999,938.03 | 18,943,802 | 2021-09-10 | Filing | |
| $108.00 | 5,231,900 | $565,045,200.00 | 5,250,491 | 2018-08-02 | Filing | |
| $108.00 | 582,200 | $62,877,600.00 | 600,791 | 2018-08-02 | Filing | |
| $101.00 | 1,645,148 | $166,159,948.00 | 5,121,404 | 2018-01-18 | Filing | |
| $101.00 | 335,050 | $33,840,050.00 | 708,025 | 2018-01-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $311.59 | 332 | $103,447.88 | 0 | 2026-04-08 | Filing | |
| $300.00 | 341 | $102,300.00 | 0 | 2026-03-11 | Filing | |
| $350.00 | 996 | $348,600.00 | 0 | 2026-02-04 | Filing | |
| $348.79 | 664 | $231,596.56 | 996 | 2026-02-04 | Filing | |
| $331.76 | 664 | $220,288.64 | 0 | 2026-01-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 259,731 | $77,132,315 | 0.4% | |
| 2. | 196,429 | $58,333,520 | 0.02% | |
| 3. | 32,532 | $9,661,028 | 0.11% | |
| 4. | 28,492 | $8,461,270 | 1.1% | |
| 5. | 5,672 | $1,684,414 | 0.13% |
News See All
7 Oversold European Stocks to Buy
European equities fell on March 27 while oil prices remained high, as concerns about the impact of conflict in the Middle East persisted despite US President Donald Trump's decision to extend the deadline...
BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment
On February 26, BeOne Medicines AG (NASDAQ:ONC) reported total global revenues of $1.5 billion for the fourth quarter of 2025 and $5.3 billion for 2026, increases of 33% and 40% from the prior-quarter...
12 Best Stocks to Buy and Hold for the Next 2 Years
Stock performance forecasts from analysts tend to focus on the next quarter or fiscal year, but a report from Citrini Research started a longer-term structural debate.
10 High Growth International Stocks to Buy Now
On February 10, Peter Boockvar, Chief Investment Officer at BFG Wealth Partners, appeared on a CNBC television interview.
Wall Street Bullish on BeOne Medicines AG (ONC) amid Robust Pipeline Development
BeOne Medicines AG (NASDAQ:ONC) is one of the best healthcare stocks to buy for 2026. On January 13, at the 44th Annual J.P.
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
Citizens Highlights BeOne Medicines’ (ONC) $3.8B Revenue Potential for 2025
BeOne Medicines Ltd. (NASDAQ:ONC) ranks among the best high growth European stocks to buy. On January 7, Citizens reaffirmed its Market Outperform rating and $396 price target for BeOne Medicines Ltd.
10 High Growth European Stocks To Buy
European equities began the last week of January in a sour mood, with investors concerned on January 26 about rising geopolitical tensions in anticipation of a Federal Reserve policy meeting and a flood...
Strong Momentum Lifted BeOne Medicines AG (ONC) in Q3
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua International and Global...
Hedge Fund Resource Center